
Herbalife is owned by Herbalife Ltd. (NYSE: HLF), a Cayman Islands holding company with its main operating base in Los Angeles, California. The parent owns the Herbalife and Herbalife Nutrition trademarks, product formulas, manufacturing assets, and distributor system. Mark Hughes founded the business in 1980. The brand now covers meal replacements, dietary supplements, sports nutrition, energy products, and skin care sold through independent distributors around the world.
Parent Company
Herbalife Ltd.
Founded
1980
Status
Publicly Traded
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Herbalife | Herbalife Ltd. | Wholly owned |
Mark Hughes started Herbalife in Los Angeles in 1980. Formula 1 shake mix became the central product, and independent distributors sold products and recruited other participants. International expansion followed during the 1980s and 1990s.
The company first entered public markets in 1986. It went private after Hughes's death, then returned to the NYSE in 2004. Herbalife expanded from meal replacements into targeted nutrition, sports products, energy, and personal care.
The distributor model drew sustained regulatory scrutiny. In 2016, Herbalife agreed to pay $200 million and restructure its U.S. operations under a Federal Trade Commission settlement. The order tied compensation more closely to verified retail sales and required detailed compliance controls.
What does Herbalife own?
Herbalife owns a single primary brand with 144 product types across weight management, targeted nutrition, energy sports and fitness, and outer nutrition categories. In 2025, the company expanded its portfolio through acquisitions of Pro2col, Link BioSciences, Pruvit, and Bioniq, building a personalization ecosystem. Its best-selling product is the Formula 1 Nutritional Shake Mix, which accounts for approximately 25% of net sales.
Is Herbalife publicly traded?
Yes, Herbalife Ltd. is publicly traded on the New York Stock Exchange under the ticker symbol HLF. The company has been listed since 2004, when it completed its IPO after a period as a private company. As of February 2026, there were approximately 103.4 million common shares outstanding.
Who founded Herbalife?
Mark Hughes founded Herbalife in 1980 in Los Angeles, California. Hughes was 24 years old at the time and started the company after his mother's struggles with unhealthy weight loss methods. He led the company until his death in 2000 at age 44. Hughes built the business through a direct sales model that recruited independent distributors to sell nutrition products.
Where is Herbalife headquartered?
Herbalife maintains its corporate headquarters in Los Angeles, California, USA. The company is legally organized as a Cayman Islands exempted holding company, with principal operations conducted through U.S. subsidiaries including Herbalife International of America, Inc. Manufacturing facilities are located in the United States, China, and India.
How many brands does Herbalife own?
Herbalife operates primarily as a single-brand company, selling products under the Herbalife name and sub-brands like Herbalife24 and Herbalife SKIN. The company has 144 product types sold in 95 markets. In 2025, Herbalife began acquiring additional brands including Pro2col, Link BioSciences, Pruvit, and Bioniq to build a multi-brand personalization platform.
Who owns Herbalife?
Herbalife is owned by its public shareholders, with institutional investors holding significant stakes. Major institutional holders have included Icahn Capital LP, Vanguard Group, and BlackRock, according to SEC 13F filings. The company does not have a dual-class share structure, so all common shares carry equal voting rights. The board is chaired by Michael O. Johnson, with Stephan Gratziani serving as CEO.
What is Herbalife's revenue?
Herbalife reported $5.0 billion in net sales for FY2025, a 0.9% increase from FY2024. On a constant currency basis, net sales increased 2.5% year-over-year. The company reported adjusted EBITDA of $657.6 million for FY2025, with an adjusted EBITDA margin of 13.1%. For Q1 2026, net sales were $1.3 billion, up 7.8% year-over-year.
Is Herbalife involved in any legal or regulatory proceedings?
Herbalife is permanently subject to a 2016 FTC consent order requiring restructured compensation practices and 80% retail sales verification. The company has settled multiple class action lawsuits, including a $32.5 million settlement in 2020. The FTC settlement required $200 million in consumer redress, and checks were sent to nearly 350,000 affected distributors. Herbalife remains under independent monitoring for FTC compliance.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Weight Watchers | USA | 1963 | Mass market | Global | All-ages |
Market Positioning: Herbalife competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Herbalife Ltd., giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is privately owned, unlike Herbalife which is under a publicly traded parent company.
Healthcare PharmaceuticalsOwned by Alcon Inc.
Independent publicly traded global eye care company headquartered in Geneva, Switzerland, specializing in surgical equipment, contact lenses, and ophthalmic products. Spun off from Novartis in April 2019.
Alcon operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
GE HealthCare operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
GoodRx operates independently without a large parent corporation.
Owned by Menicon Co., Ltd.
Japan's first and largest contact lens manufacturer, founded in 1951 in Nagoya. Known for rigid gas permeable lenses, orthokeratology, and expanding daily disposable silicone hydrogel products.
Menicon operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Novo Nordisk
Danish pharmaceutical company specializing in diabetes care and obesity treatment. Founded in 1923, headquartered in Bagsvaerd, Denmark. World leader in diabetes care and a leader in obesity treatment with Ozempic, Wegovy, and the investigational CagriSema. CEO Lars Fruergaard Jorgensen departed in March 2025; interim leadership under board chairman Helge Lund until a permanent CEO is appointed.
Novo Nordisk operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.